Starling Oncology (STLNW) Non-Current Deffered Revenue (2020 - 2021)
Starling Oncology's (STLNW) quarterly Non-Current Deffered Revenue came in at $6.3 million in Q3 2021, little changed on a YoY basis from $6.3 million in Q3 2020, and little changed quarter-over-quarter from $6.3 million in Q2 2021.
Analysis
Starling Oncology (STLNW) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
Starling Oncology (STLNW) has reported Non-Current Deffered Revenue for 2 consecutive years, with $6.3 million the latest figure, recorded in Q3 2021.
- For the quarter ending Q3 2021, Non-Current Deffered Revenue changed 0.0% year-over-year to $6.3 million; the trailing twelve-month figure through Sep 2021 stood at $6.3 million (changed 0.0% YoY), and the FY2020 full-year result was $6.3 million, changed N/A from the prior year.
- Non-Current Deffered Revenue steadied at $6.3 million in Q3 2021 per STLNW's latest filing, from $6.3 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $6.3 million in Q1 2020 and bottomed at $6.3 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | - |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | - |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | - |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | - |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | - |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | - |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | - |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 6.30 Mn |
| Jun 30, 2021 | 6.30 Mn |
| Mar 31, 2021 | 6.30 Mn |
| Dec 31, 2020 | 6.30 Mn |
| Sep 30, 2020 | 6.30 Mn |
| Jun 30, 2020 | 6.30 Mn |
| Mar 13, 2020 | 6.30 Mn |